Showing results (41-50 of 224) with videos related to

Sort By:
Pageof 23
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 15, 2005
Amaurosis fugax: associations with heritable thrombophiliaC J Glueck, Naila Goldenberg, Howard Bell, et al.
Archives of Internal Medicine|August 1, 1975
Familial hyperalphalipoproteinemiaC J Glueck, R W Fallat, F Millett, et al.
The Journal of Laboratory and Clinical Medicine|June 1, 1994
Postmenopausal cyclic estrogen-progestin therapy lowers lipoprotein[a]S Mendoza, E Velazquez, A Osona, et al.
The American Journal of Clinical Nutrition|November 1, 1976
Short term study of sucrose polyester a nonabsorbable fat-like material as a dietary agent for lowering plasma cholesterolR W Fallat, C J Glueck, R Lutmer, et al.
Metabolism: Clinical and Experimental|April 1, 1997
Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor-1, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndromeE M Velazquez, S G Mendoza, P Wang, et al.
JAMA|December 16, 1983
Weight change since age 18 years in 30- to 55-year-old whites and blacks. Associations with lipid values, lipoprotein levels, and blood pressureP Khoury, J A Morrison, M J Mellies, et al.
Circulation|November 1, 1980
Plasma high-density lipoprotein cholesterol comparisons in black and white populations. The Lipid Research Clinics Program Prevalence StudyH A Tyroler, C J Glueck, B Christensen, et al.
Clinical Orthopaedics and Related Research|January 1, 1997
Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosisC J Glueck, R Freiberg, T Tracy, et al.
Metabolism: Clinical and Experimental|August 1, 1985
Tracking of high- and low-density-lipoprotein cholesterol from childhood to young adulthood in a single large kindred with familial hypercholesterolemiaM J Mellies, P M Laskarzewski, T Tracy, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1989
Cholesterol guidelines, lipoprotein cholesterol levels, and triglyceride levels: potential for misclassification of coronary heart disease riskP Laemmle, L Unger, C McCray, et al.
Pageof 23